Granulocyte Colony–Stimulating Factor Administration: Adverse Events
- 31 October 2008
- journal article
- research article
- Published by Elsevier BV in Transfusion Medicine Reviews
- Vol. 22 (4), 280-290
- https://doi.org/10.1016/j.tmrv.2008.05.005
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent mannerBlood, 2006
- Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT)Blood, 2006
- Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptorProceedings of the National Academy of Sciences of the United States of America, 2006
- Effect of mobilization of bone marrow stem cells by granulocyte colony stimulating factor on clinical symptoms, left ventricular perfusion and function in patients with severe chronic ischemic heart diseaseInternational Journal of Cardiology, 2005
- Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosisCritical Care Medicine, 2003
- MPGN type I induced by granulocyte colony stimulating factorPediatric Nephrology, 2002
- Neutrophilic Dermatoses in Two Children with Idiopathic Neutropenia: Association with Granulocyte Colony‐Stimulating Factor (G‐CSF) TherapyPediatric Dermatology, 2001
- A generalized cutaneous reaction induced by granulocyte colony-stimulating factorJournal of the American Academy of Dermatology, 1996
- Disseminated intravascular coagulation associated with granulocyte colony-stimulating factor therapy in a child with human immunodeficiency virus infectionThe Journal of Pediatrics, 1995
- FilgrastimDrugs, 1994